Loading...
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors
Tumor targeting by genetically modified mesenchymal stromal/stem cells (MSCs) carrying anti-cancer molecules represents a promising cell-based strategy. We previously showed that the pro-apoptotic agent tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) can be successfully delivered by...
Na minha lista:
| Udgivet i: | Cancer Gene Ther |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group US
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7445885/ https://ncbi.nlm.nih.gov/pubmed/30464207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41417-018-0062-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|